Company / Income Tax per Share
Halozyme Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$1.22
FY2025
5-year range
-$0.00 / $1.22
FY2021-FY2025
Trend
+36.6%
vs FY2024
Sector context
#15 of 201
Health Care
What the data says
Among 201 Health Care companies, Halozyme is in the bottom 7% for income tax per share. Income Tax per Share has increased for 4 consecutive years, from $-0.00 in FY2021 to $1.22 in FY2025.
Based on SEC 10-K filings.
1.22 in FY2025 with a 5-year CAGR of +215.0%. Top quartile in the Health Care sector.
Increased from $0.49 to $1.22 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +53.0%
- 5-Year CAGR
- +215.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 201This company $1.22 Sector average $1.35
▼
-9.7% below sector average
Key checks
Key Insights
- Halozyme's income tax per share has grown for 4 consecutive years.
- In FY2025, income tax per share increased 36.6% year-over-year.
- Ranks #15 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 47.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 118.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.22 | +36.6% |
| FY2024 | $0.89 | +80.6% |
| FY2023 | $0.49 | +45.1% |
| FY2022 | $0.34 | +417819.7% |
| FY2021 | -$0.00 | -102.1% |
| FY2020 | $0.00 | +141.8% |
| FY2019 | -$0.01 | -350.1% |
| FY2018 | $0.00 | +135.8% |
| FY2017 | -$0.01 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026